Effects of Iron and Vitamin E on Endothelial Permeability of Aorta and Coronary Arteries in Rabbits on a High-Cholesterol Diet

Document Type : Original Article (s)

Authors

1 Associate Professor, Department of Physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 General Practitioner, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 Associate Professor, Department of Anatomy, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Atherosclerosis is the leading cause of cardiovascular diseases. The relationship between enhanced endothelial permeability and initiation or progression of atherosclerosis has been indicated in previous studies. The aim of this study was to investigate the effects of iron (Fe) and vitamin E on endothelial permeability of aorta and coronary arteries in rabbits on a high-cholesterol diet.Methods: Thirty male rabbits were randomly divided into five groups of 6, namely control, hypercholesterolemic (HC), HC + Fe (50 mg/kg), HC + vitamin E (50 mg/kg), and HC + Fe + vitamin E. After 4 weeks, blood samples were taken and endothelial permeability was measured by Evans blue dye method.Findings: Administration of Fe and/or vitamin E improved serum lipid profile (P < 0.05). Administration of Fe could not change aortic endothelial permeability in hypercholesterolemic animals (P > 0.05). However, vitamin E reduced aortic endothelial permeability (P < 0.05). Fe and vitamin E did not alter coronary artery permeability (P > 0.05). Conclusion: It seems that the effects of Fe on atherosclerosis are not through the alteration of vascular permeability. However, reduced endothelial permeability may be a mechanism for beneficial effects of vitamin E on cardiovascular system.

Keywords

References

  1. Keaney JF, Jr. Atherosclerosis: from lesion formation to plaque activation and endothelial dysfunction. Mol Aspects Med 2000; 21(4-5): 99-166.
  2. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999; 340(2): 115-26.
  3. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999; 138(5 Pt 2): S419-S420.
  4. Sullivan JL. Iron in arterial plaque: modifiable risk factor for atherosclerosis. Biochim Biophys Acta 2009; 1790(7): 718-23.
  5. Dabbagh AJ, Mannion T, Lynch SM, Frei B. The effect of iron overload on rat plasma and liver oxidant status in vivo. Biochem J 1994; 300 ( Pt 3): 799-803.
  6. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992; 86(3): 803-11.
  7. Dabbagh AJ, Shwaery GT, Keaney JF, Jr., Frei B. Effect of iron overload and iron deficiency on atherosclerosis in the hypercholesterolemic rabbit. Arterioscler Thromb Vasc Biol 1997; 17(11): 2638-45.
  8. Khazaei M, Haghparast E, Afshar M. Do l-arginine and l-name alter coronary vascular and Aortic endothelial permeability in normal- and highcholesterol-fed rats? ARYA Atherosclerosis Journal 2007; 3(2): 77-80.
  9. Chandra AK, Chatterjee A, Ghosh R, Sarkar M. Vitamin E-supplementation protect chromium (VI)-induced spermatogenic and steroidogenic disorders in testicular tissues of rats. Food Chem Toxicol 2010; 48(3): 972-9.
  10. Sitniewska EM, Wisniewska RJ. Influence of secretin and L-NAME on vascular permeability in the coronary circulation of intact and diabetic rats. Regul Pept 2001; 96(3): 105-11.
  11. Khazaei M, Nematbakhsh M. Coronary vascular and aortic endothelial permeability during estrogen therapy: a study in DOCA-salt hypertensive ovariectomized rats. Physiol Res 2004; 53(6): 609-14.
  12. Lamack JA, Himburg HA, Friedman MH. Effect of hypercholesterolemia on transendothelial EBD-albumin permeability and lipid accumulation in porcine iliac arteries. Atherosclerosis 2006; 184(2): 255-63.
  13. Rajendran R, Ren M, Ning P, Tan Kwong HB, Halliwell B, Watt F. Promotion of atherogenesis by copper or iron--which is more likely? Biochem Biophys Res Commun 2007; 353(1): 6-10.
  14. Minqin R, Rajendran R, Pan N, Tan BK, Ong WY, Watt F, et al. The iron chelator desferrioxamine inhibits atherosclerotic lesion development and decreases lesion iron concentrations in the cholesterol-fed rabbit. Free Radic Biol Med 2005; 38(9): 1206-11.
  15. Juan SH, Lee TS, Tseng KW, Liou JY, Shyue SK, Wu KK, et al. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 2001; 104(13): 1519-25.
  16. Kirk EA, Heinecke JW, LeBoeuf RC. Iron overload diminishes atherosclerosis in apoE-deficient mice. J Clin Invest 2001; 107(12): 1545-53.
  17. Turbino-Ribeiro SM, Silva ME, Chianca DA, Jr., De PH, Cardoso LM, Colombari E, et al. Iron overload in hypercholesterolemic rats affects iron homeostasis and serum lipids but not blood pressure. J Nutr 2003; 133(1): 15-20.
  18. Kirmizis D, Chatzidimitriou D. Antiatherogenic effects of vitamin E: the search for the Holy Grail. Vasc Health Risk Manag 2009; 5: 767-74.
  19. Saremi A, Arora R. Vitamin E and cardiovascular disease. Am J Ther 2010; 17(3): e56-e65.
Journal of Isfahan Medical School
Volume 29, Issue 160 - Serial Number 160
September and October 2011
Pages 1737-1743

Files

History

  • Receive Date: 05 September 2011
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics